1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Renal Anemia Global Clinical Trials Review, H2, 2014

Renal Anemia Global Clinical Trials Review, H2, 2014

  • December 2014
  • -
  • Global Data
  • -
  • 81 pages

Renal Anemia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Renal Anemia Global Clinical Trials Review, H2, 2014" provides data on the Renal Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Anemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Anemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Renal Anemia Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Anemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Anemia to Hematological Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Anemia to Hematological Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Renal Anemia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Renal Anemia Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Renal Anemia 32
Oct 15, 2014: Medgenics Reports Positive Initial Clinical Data From Clinical Study Of MDGN-201 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
FibroGen, Inc. 40
Clinical Trial Overview of FibroGen, Inc. 40
Astellas Pharma Inc. 42
Clinical Trial Overview of Astellas Pharma Inc. 42
Takeda Pharmaceutical Company Limited 43
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43
Amgen Inc. 44
Clinical Trial Overview of Amgen Inc. 44
GlaxoSmithKline plc 45
Clinical Trial Overview of GlaxoSmithKline plc 45
Bayer AG 46
Clinical Trial Overview of Bayer AG 46
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
Kirin Holdings Company, Limited 48
Clinical Trial Overview of Kirin Holdings Company, Limited 48
AstraZeneca PLC 49
Clinical Trial Overview of AstraZeneca PLC 49
Clinical Trial Overview of Top Institutes / Government 50
Hyogo College Of Medicine 50
Clinical Trial Overview of Hyogo College Of Medicine 50
Yokohama City University 51
Clinical Trial Overview of Yokohama City University 51
J-CRSU 52
Clinical Trial Overview of J-CRSU 52
Shanghai Changzheng Hospital 53
Clinical Trial Overview of Shanghai Changzheng Hospital 53
Kansai Medical University 54
Clinical Trial Overview of Kansai Medical University 54
Kanazawa Medical University 55
Clinical Trial Overview of Kanazawa Medical University 55
Juntendo University 56
Clinical Trial Overview of Juntendo University 56
Chiba University 57
Clinical Trial Overview of Chiba University 57
Ministry of Health, Malaysia 58
Clinical Trial Overview of Ministry of Health, Malaysia 58
University of Maryland 59
Clinical Trial Overview of University of Maryland 59
Five Key Clinical Profiles 60
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables
Renal Anemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Renal Anemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Anemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Anemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Renal Anemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Renal Anemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Renal Anemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Renal Anemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Renal Anemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2014* 15
Renal Anemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Anemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Anemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2014* 18
Renal Anemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Anemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Renal Anemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Renal Anemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Renal Anemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Renal Anemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Renal Anemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Renal Anemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Renal Anemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Renal Anemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Renal Anemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Renal Anemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Renal Anemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 33
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by FibroGen, Inc., 2014* 40
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 42
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 43
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 44
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 45
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 46
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 47
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2014* 48
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 49
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2014* 50
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2014* 51
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by J-CRSU, 2014* 52
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2014* 53
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Medical University, 2014* 54
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa Medical University, 2014* 55
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University, 2014* 56
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2014* 57
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Malaysia, 2014* 58
Renal Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2014* 59

List of Figures
Renal Anemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Renal Anemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Anemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Anemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Renal Anemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Renal Anemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Renal Anemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Renal Anemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Renal Anemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2014* 15
Renal Anemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Anemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Anemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2014* 18
Renal Anemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Anemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Renal Anemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Renal Anemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Renal Anemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Renal Anemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Renal Anemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Renal Anemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Renal Anemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Renal Anemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Renal Anemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.